127 related articles for article (PubMed ID: 38219878)
1. Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaques.
Shao X; Zeng W; Wang Q; Liu S; Guo Q; Luo D; Luo Q; Wang D; Wang L; Zhang Y; Diao H; Piao S; Yan M; Guo J
J Ethnopharmacol; 2024 Apr; 324():117705. PubMed ID: 38219878
[TBL] [Abstract][Full Text] [Related]
2. The Chinese herbal medicine Fufang Zhenzhu Tiaozhi protects against diabetic cardiomyopathy by alleviating cardiac lipotoxicity-induced oxidative stress and NLRP3-dependent inflammasome activation.
Yan M; Li L; Wang Q; Shao X; Luo Q; Liu S; Li Y; Wang D; Zhang Y; Diao H; Rong X; Guo J
Biomed Pharmacother; 2022 Apr; 148():112709. PubMed ID: 35190353
[TBL] [Abstract][Full Text] [Related]
3. Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome.
Zhang X; Wang Z; Li X; Chen J; Yu Z; Li X; Sun C; Hu L; Wu M; Liu L
J Ethnopharmacol; 2023 Jun; 309():116304. PubMed ID: 36870461
[TBL] [Abstract][Full Text] [Related]
4. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway.
Diao H; Cheng J; Huang X; Huang B; Shao X; Zhao J; Lan D; Zhu Q; Yan M; Zhang Y; Rong X; Guo J
J Ethnopharmacol; 2022 Jul; 293():115261. PubMed ID: 35447198
[TBL] [Abstract][Full Text] [Related]
5. Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m
Zhang Y; Wang R; Tan H; Wu K; Hu Y; Diao H; Wang D; Tang X; Leng M; Li X; Cai Z; Luo D; Shao X; Yan M; Chen Y; Rong X; Guo J
J Ethnopharmacol; 2023 Dec; 317():116766. PubMed ID: 37343655
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 Inflammasome Formation and Activation in Nonalcoholic Steatohepatitis: Therapeutic Target for Antimetabolic Syndrome Remedy FTZ.
Chen Y; He X; Yuan X; Hong J; Bhat O; Li G; Li PL; Guo J
Oxid Med Cell Longev; 2018; 2018():2901871. PubMed ID: 30140364
[TBL] [Abstract][Full Text] [Related]
7. The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease.
Song L; Zhang D; Guo C; Gu Z; Wang L; Yao YS; Wang H; Zeng Z; Wang W; Yang Y; Bei W; Rong X; Guo J
Biomed Pharmacother; 2021 May; 137():111343. PubMed ID: 33761594
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
9. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease.
Yang YQ; Tan HB; Zhang XY; Zhang YZ; Lin QY; Huang MY; Lin ZY; Mo JZ; Zhang Y; Lan T; Bei WJ; Guo J
J Ethnopharmacol; 2022 Jun; 292():115165. PubMed ID: 35247475
[TBL] [Abstract][Full Text] [Related]
10. Fufang-Zhenzhu-Tiaozhi Capsule reduces restenosis via the downregulation of NF-kappaB and inflammatory factors in rabbits.
Zhang R; Li T; Guo J; Zhao Y; Liu Y; Yao Y; Zeng Z
Lipids Health Dis; 2018 Nov; 17(1):272. PubMed ID: 30497486
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid B inhibits atherosclerosis and TNF-α-induced inflammation by regulating NF-κB/NLRP3 signaling pathway.
Zhao Y; Shao C; Zhou H; Yu L; Bao Y; Mao Q; Yang J; Wan H
Phytomedicine; 2023 Oct; 119():155002. PubMed ID: 37572566
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-derived mesenchymal stem cells microvesicles stabilize atherosclerotic plaques by inhibiting NLRP3-mediated macrophage pyroptosis.
Lin Y; Liu M; Chen E; Jiang W; Shi W; Wang Z
Cell Biol Int; 2021 Apr; 45(4):820-830. PubMed ID: 33325118
[TBL] [Abstract][Full Text] [Related]
13. Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis.
Qiao L; Ma J; Zhang Z; Sui W; Zhai C; Xu D; Wang Z; Lu H; Zhang M; Zhang C; Chen W; Zhang Y
Circ Res; 2021 Dec; 129(12):1141-1157. PubMed ID: 34704457
[TBL] [Abstract][Full Text] [Related]
14. The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice.
Yan M; Liu S; Zeng W; Guo Q; Mei Y; Shao X; Su L; Liu Z; Zhang Y; Wang L; Diao H; Rong X; Guo J
Biomed Pharmacother; 2023 Aug; 164():114919. PubMed ID: 37302318
[TBL] [Abstract][Full Text] [Related]
15. LncRNA Gaplinc promotes the pyroptosis of vascular endothelial cells through SP1 binding to enhance NLRP3 transcription in atherosclerosis.
Tang Y; Yan JH; Ge ZW; Fei AH; Zhang YC
Cell Signal; 2022 Nov; 99():110420. PubMed ID: 35901931
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis.
Burger F; Baptista D; Roth A; da Silva RF; Montecucco F; Mach F; Brandt KJ; Miteva K
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008765
[TBL] [Abstract][Full Text] [Related]
17. miR-155 activates the NLRP3 inflammasome by regulating the MEK/ERK/NF-κB pathway in carotid atherosclerotic plaques in ApoE
Peng Q; Yin R; Zhu X; Jin L; Wang J; Pan X; Ma A
J Physiol Biochem; 2022 May; 78(2):365-375. PubMed ID: 35079982
[TBL] [Abstract][Full Text] [Related]
18. NR1D1 Deletion Induces Rupture-Prone Vulnerable Plaques by Regulating Macrophage Pyroptosis via the NF-
Wu Z; Liao F; Luo G; Qian Y; He X; Xu W; Ding S; Pu J
Oxid Med Cell Longev; 2021; 2021():5217572. PubMed ID: 34956438
[TBL] [Abstract][Full Text] [Related]
19. Fufang-zhenzhu-tiaozhi formula protects islet against injury and promotes β cell regeneration in diabetic mice.
Chen X; Yin J; Zhong Q; Wang K; Zhang X; Liang M; Lin Q; Wang H; Wang W; Wang L; Hu X; Bei W; Guo J
J Ethnopharmacol; 2023 Jan; 301():115791. PubMed ID: 36240976
[TBL] [Abstract][Full Text] [Related]
20. Fufang-Zhenzhu-Tiaozhi capsule ameliorates rabbit's iliac artery restenosis by regulating adiponectin signaling pathway.
Li T; Zhang R; Liu Y; Yao Y; Guo J; Zeng Z
Biomed Pharmacother; 2020 Aug; 128():110311. PubMed ID: 32502838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
